Episode #386: Longevity Myths- Biological Clocks, GLP-1 Muscle Loss, and What Actually Predicts Lifespan

The longevity industry is now worth over $100 billion per year. From DNA methylation clocks to multi-cancer blood tests and GLP-1 medications, the promises are bold. But what actually predicts lifespan? In this episode, Dr. Jordan Feigenbaum and Dr. Austin Baraki break down the science behind biological clocks, the real story on GLP-1–related muscle loss, and introduce the Barbell Medicine “Vital Five” — a clinically grounded framework for health and longevity. Key Points: The Three Generations of Biological Clocks: Understanding the evolution of DNA methylation tests from simple chronological markers (Horvath) to sophisticated predictors of mortality (GrimAge) and functional decline (DunedinPACE). Descriptive vs. Prescriptive Metrics: Why a biological age score acts as a lagging indicator rather than a tool for clinical decision-making, compared to traditional risk factors like blood pressure and ApoB. GLP-1s and Sarcopenia Reality: A nuanced look at lean mass loss during semaglutide and tirzepatide treatment, emphasizing the difference between total lean mass and actual skeletal muscle quality. Weight-Independent Benefits of Incretins: Analyzing data from the SELECT and FLOW trials regarding the direct cardioprotective and renal benefits of GLP-1 receptor agonists. The Limitations of Early Detection: Why multi-cancer early detection (MCED) tests can lead to diagnostic loops and how clinical utility differs from marketing promises. The Barbell Medicine Vital Five: A definitive framework for longevity focusing on blood pressure, ApoB, VO2 max, relative strength, and body composition. Neurodegenerative Research Outlook: A critical review of the EVOKE trials and the potential (or lack thereof) for current weight-loss medications in treating established Alzheimer's disease. Next Steps For evidence-based resistance training programs: barbellmedicine.com/training-programs For individualized training consultation: barbellmedicine.com/coaching Explore our full library of articles on health and performance: barbellmedicine.com/resources To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: To consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.com Timestamps: 00:00 Overview: longevity industry and proxy metrics 01:06 Biological age and DNA methylation clocks 08:18 Clinical usefulness and limitations of biological age testing 16:16 Multi-cancer early detection tests: screening tradeoffs 30:39 Exercise prescription for longevity (treat-to-target) 54:39 Protein intake and longevity: evidence and recommendations 1:07:23 GLP-1 receptor agonists: outcomes, misconceptions, and use cases 1:34:24 Hormone therapy (women and men): risks, benefits, evidence 1:49:19 Practical longevity tracking: “Vital Five” markers 1:58:15 Closing References: Biological Clock Cancer Screening Exercise ​​ Protein GLP-1 HRT Body Roundness Index (BRI) : Our Sponsors: * Check out FIGS and use my code wearfigs.com for a great deal: * Check out Factor and use my code factormeals.com/bbm50off for a great deal: * Check out Quince and use my code quince.com/bbm for a great deal: Advertising Inquiries: Privacy & Opt-Out:

You can listen to Episode #386: Longevity Myths- Biological Clocks, GLP-1 Muscle Loss, and What Actually Predicts Lifespan online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode #386: Longevity Myths- Biological Clocks, GLP-1 Muscle Loss, and What Actually Predicts Lifespan is an episode from Barbell Medicine Podcast by Barbell Medicine.

This episode is 120:17 long.

This episode was published on Feb 13, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Barbell Medicine Podcast when more episodes are available from the podcast feed.